Minerva Neurosciences reported $4K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Adma Biologics ADMA:US $ 0.01M 0M
ALKERMES ALKS:US $ 1.65M 0.01M
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
AstraZeneca AZN:LN 328M 0M
BioSpecifics Technologies BSTC:US 7.83K 0
Bristol Myers Squibb BMY:US $ 292M 0M
Dynavax Technologies DVAX:US $ 0.11M 0M
Eli Lilly And LLY:US $ 598.1M 1.6M
Esperion Therapeutics ESPR:US $ 26K 0
GlaxoSmithKline GSK:LN 1347M 1M
Halozyme Therapeutics HALO:US $ 0.14M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Johnson & Johnson JNJ:US $ 3120M 0M
Kindred Biosciences KIN:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 0.04M 0M
Minerva Neurosciences NERV:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 913M 0M
Novavax NVAX:US $ 0.75M 0M
Takeda 4502:JP Y 1669125M 980M
Vanda Pharmaceuticals VNDA:US $ 0.06M 0M